日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

EVI-1 modulates leukemogenic potential and apoptosis sensitivity in human acute lymphoblastic leukemia

EVI-1 调节人类急性淋巴细胞白血病的致白血病潜能和凋亡敏感性

M Konantz, M C André, M Ebinger, M Grauer, H Wang, S Grzywna, O C Rothfuss, S Lehle, O S Kustikova, H R Salih, R Handgretinger, F Fend, C Baum, L Kanz, L Quintanilla-Martinez, K Schulze-Osthoff, F Essmann, C Lengerke

Targeted therapy of the XIAP/proteasome pathway overcomes TRAIL-resistance in carcinoma by switching apoptosis signaling to a Bax/Bak-independent 'type I' mode

XIAP/蛋白酶体通路的靶向治疗通过将凋亡信号转换为 Bax/Bak 独立的“I 型”模式来克服癌症中的 TRAIL 抗性

B Gillissen, A Richter, A Richter, T Overkamp, F Essmann, P G Hemmati, R Preissner, C Belka, P T Daniel